Compounds > hexacyclinol
Page last updated: 2024-11-12

hexacyclinol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

hexacyclinol: an antiproliferative metabolite of Panus rudis HKI 0254; structure in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID11975375
MeSH IDM0443713

Synonyms (12)

Synonym
hexacyclinol
(+)-hexacyclinol
Q10860972
unii-ug4ywn1cpx
hexacyclinol [mi]
(1as,2as,3s,5as,6as,7r,7as,7bs,8r,8as,10r)-7-hydroxy-3-(1-methoxy-1-methylethyl)-10-(2-methyl-1-propenyl)-1a,5a,6a,7,7a,7b,8,8a-octahydro-2h-8,2a-(epoxymethano)phenanthro(2,3-b:6,7-b')bisoxirene-2,5(3h)-dione
(2as,3r,5ar,6as,7r,8r,8as,10r)-7-hydroxy-3-(1-methoxy-1-methylethyl)-10-(2-methylprop-1-en-1-yl)-1a,5a,6a,7,7a,7b,8,8a-octahydro-2h-8,2a-(epoxymethano)phenanthro(2,3-b:6,7-b')bisoxirene-2,5(3h)-dione
2h-8,2a-(epoxymethano)phenanthro(2,3-b:6,7-b')bisoxirene-2,5(3h)-dione, 1a,5a,6a,7,7a,7b,8,8a-octahydro-7-hydroxy-3-(1-methoxy-1-methylethyl)-10-(2-methyl-1-propen-1-yl)-, (1as,2as,3s,5as,6as,7r,7as,7bs,8r,8as,10r)-
ug4ywn1cpx ,
903574-41-4
DTXSID101029628
(1s,2s,6s,8s,9r,10s,11s,12r,13s,15s,17r)-9-hydroxy-2-(2-methoxypropan-2-yl)-17-(2-methylprop-1-enyl)-7,14,18-trioxahexacyclo[10.4.2.01,11.04,10.06,8.013,15]octadec-3-ene-5,16-dione
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (11)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's8 (72.73)29.6817
2010's3 (27.27)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 21.15

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be moderate demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index21.15 (24.57)
Research Supply Index2.48 (2.92)
Research Growth Index4.33 (4.65)
Search Engine Demand Index18.60 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (21.15)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (9.09%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other10 (90.91%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
SubstanceRelationship StrengthStudiesTrialsClassesRoles
panepophenanthrin
panepophenanthrin: from a mushroom strain, an inhibitor of the ubiquitin-activating enzyme; structure in first source		2.0510
plakotenin
plakotenin: from the Palauan sponge Plakortis lita; structure in first source		3.1810
phenanthrenes
Phenanthrenes: POLYCYCLIC AROMATIC HYDROCARBONS composed of three fused BENZENE rings.. phenanthrenes : Any benzenoid aromatic compound that consists of a phenanthrene skeleton and its substituted derivatives thereof.		2.0510
ConditionIndicatedRelationship StrengthStudiesTrials